Acceleron to Participate in the 38th Annual J.P. Morgan Healthcare Conference
Monday, January 13, 2020, Habib Dable, Acceleron’s President and Chief Executive Officer, will present an overview of the company at 9:30 a.m. PST/ 12:30 p.m. EST.
Immediately following the presentation, the senior management team will participate in a question and answer breakout session at
10:00 a.m. PST/ 1:00 p.m. EST.
A live webcast of the presentation and breakout session will be accessible under “Events and Presentations” in the Investors & Media page of the Company's website at www.acceleronpharma.com. A replay of the webcasts will be available approximately two hours after the event on the Acceleron website.
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. The Company's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Acceleron focuses its research and development efforts in hematologic, neuromuscular, and pulmonary diseases. In hematology, Acceleron and its global collaboration partner,
Acceleron Pharma Inc.
Todd James, 617-649-9393
Vice President, Investor Relations and Corporate Communications
Ed Joyce, 617-649-9242
Director, Investor Relations
Matt Fearer, 617-301-9557
Director, Corporate Communications